These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4783660)

  • 61. Sero-immunity to poliovirus in children and young women: England 1972-4.
    Mortimer PP; Cunningham P
    J Hyg (Lond); 1975 Apr; 74(2):283-7. PubMed ID: 164503
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunity against contagious diseases: inadequacies.
    Hussey HH
    JAMA; 2015 Apr; 313(15):1577. PubMed ID: 25898065
    [No Abstract]   [Full Text] [Related]  

  • 63. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
    Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Seroimmunity to poliomyelitis in an American community.
    Oberhofer TR; Brown GC; Monto AS
    Am J Epidemiol; 1975 Apr; 101(4):333-9. PubMed ID: 164770
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Seroprevalence of antibodies to measles, rubella, mumps, hepatitis B viruses and all three poliovirus serotypes among children in Quindío, Colombia].
    González MM; Sarmiento L; Giraldo AM; Padilla L; Rey-Benito G; Castaño JC
    Rev Salud Publica (Bogota); 2016 Feb; 18(1):95-103. PubMed ID: 28453157
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Editorial: Immunity against contagious diseases: inadequacies.
    Hussey HH
    JAMA; 1974 Feb; 227(7):797-8. PubMed ID: 4405849
    [No Abstract]   [Full Text] [Related]  

  • 67. RESPONSE TO ONE DOSE OF TRIVALENT ORAL POLIOVACCINE IN CHILDREN PREVIOUSLY IMMUNISED WITH SALK VACCINE: A COMPARISON OF LIQUID VACCINE AND A CAPSULE PRESENTATION.
    BEALE AJ; DAVIES JR; THROWER AL
    Lancet; 1965 Apr; 1(7391):879-81. PubMed ID: 14272682
    [No Abstract]   [Full Text] [Related]  

  • 68. Immunization against poliomyelitis.
    Beale AJ
    Br Med Bull; 1969 May; 25(2):148-52. PubMed ID: 4319086
    [No Abstract]   [Full Text] [Related]  

  • 69. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
    Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
    Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recommendations for a national policy on poliomyelitis vaccination.
    Nightingale EO
    N Engl J Med; 1977 Aug; 297(5):249-53. PubMed ID: 195207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [On the problem of revaccination against poliomyelitis. Results of a reinfection experiment using the poliovirus type 1, strain "LSc, 2ab (Sabin)". 4 and half years following original vaccination].
    Kuwert E; Posch J; Lagarie G
    Med Klin; 1968 May; 63(18):701-7. PubMed ID: 4305218
    [No Abstract]   [Full Text] [Related]  

  • 72. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. II. Parallel vaccinations and cross-wise revaccination in school children with the Sabin and WM3 attenuated strains.
    Böttiger M
    J Pediatr; 1969 Aug; 75(2):273-80. PubMed ID: 4307564
    [No Abstract]   [Full Text] [Related]  

  • 73. Further evaluation of the optimum age for rubella vaccine administration.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Investigations on immunity against poliomyelitis (author's transl)].
    Haas R; Petersen EE; Neumann-Haefelin D; Doerr HW; Eggert E; Enders G; Firtzlaff R; Kuwert E; Lennartz H; Schmidt WA
    Dtsch Med Wochenschr; 1975 Jan; 100(1):3-8. PubMed ID: 163177
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan].
    Akoua-Koffi G; Thonnon J; Kouassi-Renaud M; Dosso M; Ehouman A
    Bull Soc Pathol Exot; 1995; 88(3):117-20. PubMed ID: 8555765
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Humoral poliomyelitis immunity in children inoculated with a live poliomyelitis vaccine].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
    Vopr Virusol; 1984; 29(2):251-3. PubMed ID: 6328770
    [No Abstract]   [Full Text] [Related]  

  • 77. Current status of active immunization procedures.
    Ferrer-Pí S; Roldán ML
    Paediatrician; 1979; 8(1-2):83-92. PubMed ID: 471518
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Natural immunity to measles, rubella and mumps among Spanish children in the pre-vaccination era.
    Arroyo M; Alia JM; Mateos ML; Carrasco JL; Ballesteros F; Lardinois R
    Int J Epidemiol; 1986 Mar; 15(1):95-100. PubMed ID: 3957548
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
    Buxbaum S; Doerr HW; Allwinn R
    Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Humoral antibodies, coproantibodies and viral excretion in newborn infants immunized with poliomyelitis vaccine].
    Ruíz-Gómez J; Caloca García MA; Longega Escobio P
    Salud Publica Mex; 1979; 21(2):127-34. PubMed ID: 231330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.